Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Search Evidence

Wla
All
All (none selected)
Filters:
Heme
# PMID Evidence Tag
Evidence
Subspecialty
Complexity
Importance
PDF
1 36089857
A Shah 2023
Major haemorrhage: past, present and future. Heme
D
  PDF
2 36314081
Nayha Tahir 2022
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature. Heme
D
3 34528390
Yael Shahal-Zimra 2022
Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis. Heme
D
4 35461807
Joseph Hulsizer 2022
Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK Biobank. Heme
D
5 35550484
Tuula Pelkonen 2022
Bacterial Meningitis in Children With Sickle Cell Disease in Angola. Heme
D
  PDF
6 35405030
Theodore E Warkentin 2022
How to dose and monitor argatroban for treatment of HIT. Heme
D
7 35535578
Daniel Jarovsky 2022
Vaccination in Pediatric Patients with Sickle-Cell Disease: Uptake Report and Mini-Review. Heme
D
8 34996762
Aditi Kumar 2022
Iron deficiency anaemia: pathophysiology, assessment, practical management. Heme
E
  PDF
9 36105295
Sari Peretz 2022
The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism. Heme
D
  PDF
10 34480106
Ayalew Tefferi 2021
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Heme
E
  PDF
11 34785603
Alexandra L Czap 2021
Overview of Imaging Modalities in Stroke. Heme
E
12 34168126
Erik Berntorp 2021
Haemophilia. Heme
D
13 34307650
Nur Samsu 2021
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Heme
E
  PDF
14 33790795
Germana Bancone 2021
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs. Heme
D
  PDF
15 32212518
M Domenica Cappellini , NEJM 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. Heme
D
16 33102497
Ferras Alashkar 2020
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation. Heme
E
  PDF
17 31591741
Elsa Maitre 2019
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Heme
D
18 31483965
Nichola Cooper , NEJM 2019
Immune Thrombocytopenia. Heme
E
19 31477227
Karen Schreiber 2019
Managing antiphospholipid syndrome in pregnancy. Heme
D
20 30510080
Jong Wook Lee 2019
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Heme
D
21 30282668
Imad Uthman , ANRD 2019
Management of antiphospholipid syndrome. Heme
E
22 30454745
Catherine Kavanagh 2019
Nephrogenic Diabetes Insipidus. Heme
E
23 31571940
Sarah Luu 2019
Post-splenectomy sepsis: preventative strategies, challenges, and solutions. Heme
E
  PDF
24 30171728
Timothy Devos 2018
Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel. Heme
E
25 30039550
Ayalew Tefferi 2018
Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management. Heme
E
26 30182925
Yantian Zhao 2018
Basophilic Stippling and Chronic Lead Poisoning Heme
E
  PDF
27 29546732
Ruchita Dixit , COCHD 2018
Folate supplementation in people with sickle cell disease. Heme
D
  PDF
28 28544333
Oguzhan Angay 2018
Image-based modeling and scoring of Howell-Jolly Bodies in human erythrocytes. Heme
D
  PDF
29 29203195
Gordon F Tomaselli 2017
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. Heme
D
30 27756061
Anazoeze Jude Madu 2017
Anaemia of Chronic Disease: An In-Depth Review. Heme
E
  PDF
31 27488143
Chatree Chai-Adisaksopha 2016
Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Heme
E
32 27374723
Jonathan Lai 2016
Fetal movements as a predictor of health. Heme
E
  PDF
33 26676927
Alessandro Squizzato 2016
Supportive management strategies for disseminated intravascular coagulation. An international consensus. Heme
D
34 26676927
Alessandro Squizzato 2016
Supportive management strategies for disseminated intravascular coagulation. An international consensus. Heme
D
35 26813211
Albert L Siu , JAMA 2016
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. Heme
E
36 26079040
Gwen Murphy 2015
Cancer Risk After Pernicious Anemia in the US Elderly Population. Heme
E
  PDF
37 25879992
O Pourrat 2015
Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators. Heme
M 5
D
38 26043383
Daimon P Simmons 2015
Hemolysis from ABO Incompatibility. Heme
E
39 25742458
Vijay G Sankaran 2015
Anemia: progress in molecular mechanisms and therapies. Heme
M 5
D
  PDF
40 25217409
Antonio Carlos Bueno Filho 2015
Raman spectroscopy for a rapid diagnosis of sickle cell disease in human blood samples: a preliminary study. Heme
M 5
D
41 25287707
Trisha E Wong 2014
Update on the use of hydroxyurea therapy in sickle cell disease. Heme
M 5
D
42 25506680
Berlinda Yeoh , COCHD 2014
Household interventions for preventing domestic lead exposure in children. Heme
M 5
D
43 24990367
Gabrielle Paoletti 2014
Severe iron-deficiency anemia still an issue in toddlers. Heme
D
44 25831638
Amyn Pardhan 2014
Outcomes of splenectomy for idiopathic thrombocytopenic purpura in adults: a developing country perspective. Heme
M 5
D
45 25246627
Bolaji O Badejoko , PEDS 2014
Early neonatal bilirubin, hematocrit, and glucose-6-phosphate dehydrogenase status. Heme
M 5
D
46 25180279
Howard M Lederman , PEDS 2014
Immunologic effects of hydroxyurea in sickle cell anemia. Heme
M 5
D
  PDF
47 25122831
M Elisabeth Del Giudice 2014
Systematic review of clinical features of suspected colorectal cancer in primary care. Heme
M 5
D
  PDF
48 25073783
Krista S Crider , BMJ 2014
Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. Heme
M 5
D
49 24862308
Valentine Brousse 2014
The spleen and sickle cell disease: the sick(led) spleen. Heme
M 5
D
50 24784336
Amanda S Davis , AFP 2014
Leukemia: an overview for primary care. Heme
M 5
D
51 24618088
Yujin Kobayashi 2014
Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature. Heme
M 5
D
  PDF
52 23954454
Massimo Cugno 2014
Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy. Heme
M 5
D
53 24523598
Piers Blombery 2014
Management of thrombotic thrombocytopenic purpura: current perspectives. Heme
M 5
D
  PDF
54 24812610
Laila M Sherief 2014
Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experience. Heme
M 5
D
  PDF
55 24365370
Chirag Amin 2014
Bleeding diathesis and hemophilias. Heme
M 5
D
56 24644537
Ali Nayer 2014
Catastrophic antiphospholipid syndrome: a clinical review. Heme
M 5
D
  PDF
57 24182446
Andreas Alexandrou 2014
Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study. Heme
D
58 24335401
H P Pham 2013
Update on massive transfusion. Heme
M 5
D
59 24364522
Victoria J Sharp , AFP 2013
Assessment of asymptomatic microscopic hematuria in adults. Heme
M 5
D
60 24237980
Riten Kumar 2013
Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond. Heme
M 5
D
61 23774773
William L Neumann 2013
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Heme
M 5
D
62 23786647
Anjali Shah 2013
Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study. Heme
M 5
D
63 23664421
Lydie Da Costa 2013
Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Heme
M 5
D
64 23549631
Eric Mariotte 2013
Unresponsive thrombotic thrombocytopenic purpura in critically ill adults. Heme
M 5
D
65 23782084
Jennifer Webb 2013
Stroke in patients with sickle cell disease. Heme
D
66 23423840
Matthew J Oberley 2013
Laboratory testing for cobalamin deficiency in megaloblastic anemia. Heme
M 5
D
67 23550040
Cindy E Neunert 2013
Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Heme
M 5
D
68 23569332
John L Wallace 2013
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. Heme
M 5
D
  PDF
69 23451962
Huyen A Tran 2013
An update of consensus guidelines for warfarin reversal. Heme
M 5
D
70 24385759
Tay Za Kyaw 2013
Acquired Factor VIII Inhibitors: Three Cases. Heme
M 5
D
  PDF
71 23317073
Matthew W Short , AFP 2013
Iron deficiency anemia: evaluation and management. Heme
M 5
D
72 23118217
H Franklin Bunn 2013
The triumph of good over evil: protection by the sickle gene against malaria. Heme
M 5
D
73 23073045
John A D'Orazio 2013
ITP in children: pathophysiology and current treatment approaches. Heme
E
74 23099069
C Chidiac 2012
Pneumococcal infections and adult with risk factors. Heme
D
75 22280352
F Dituri 2012
PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants. Heme
M 5
D
76 21911282
Kharmene L Sunga 2012
Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome. Heme
M 5
D
77 22315270
Lori-Ann Linkins 2012
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Heme
M 5
D
  PDF
78 22315268
Clive Kearon 2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Heme
M 5
D
  PDF
79 23049459
Rajasekharan Warrier 2012
Management of immune thrombocytopenic purpura: an update. Heme
E
  PDF
80 22168590
Jeffrey L Carson , NEJM 2011
Liberal or restrictive transfusion in high-risk patients after hip surgery. Heme
M 5
D
  PDF
81 21911832
Renato D Lopes 2011
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. Heme
D
82 21556950
Hyoung-Il Kim 2011
Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Heme
M 5
D
83 21841559
Martin A Schreiber , JTACS 2011
The use of normal saline for resuscitation in trauma. Heme
E
84 21404983
Sanjeev Sharma , AFP 2011
Transfusion of blood and blood products: indications and complications. Heme
M 5
D
85 21302870
Nicholas J Galioto , AFP 2011
Recurrent venous thromboembolism. Heme
M 5
D
86 22084706
Ahmed H Al-Salem 2011
Splenic complications of sickle cell anemia and the role of splenectomy. Heme
M 5
D
  PDF
87 22160007
David Kavanagh 2011
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Heme
M 5
D
88 22160079
Sarah Ball 2011
Diamond Blackfan anemia. Heme
E
89 21116184
Jody Lynn Kujovich 2011
Factor V Leiden thrombophilia. Heme
D
90 21121557
Michele Van Vranken , AFP 2010
Evaluation of microcytosis. Heme
M 5
D
91 20701405
Ilan Youngster 2010
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Heme
E
92 19885711
Philippe Hernigou , CORR 2010
Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis. Heme
M 5
D
  PDF
93 20229974
Crista Warniment , AFP 2010
Lead poisoning in children. Heme
M 5
D
94 19846889
Drew Provan 2010
International consensus report on the investigation and management of primary immune thrombocytopenia. Heme
M 5
D
95 19678601
Herbert L Muncie Jr , AFP 2009
Alpha and beta thalassemia. Heme
M 5
D
96 19615543
Rosalynn M Nazarian 2009
Warfarin-induced skin necrosis. Heme
M 5
D
97 19393983
Geoffrey Tsaras 2009
Complications associated with sickle cell trait: a brief narrative review. Heme
M 5
D
98 19384085
Yaron Shapira 2009
Hemolysis associated with prosthetic heart valves: a review. Heme
D
99 19202968
Joyce Kaferle , AFP 2009
Evaluation of macrocytosis. Heme
M 5
D
100 19136438
Tomás Scholz 2009
Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Heme
M 5
D
  PDF
101 18779222
Mariane de Montalembert , BMJ 2008
Management of sickle cell disease. Heme
M 5
D
102 18619081
Lee T Dresang , AFP 2008
Venous thromboembolism during pregnancy. Heme
M 5
D
103 18540496
US Preventive Services Task Force , AFP 2008
Screening for sickle cell disease in newborns: recommendation statement. Heme
M 5
D
104 18081686
Rainer Wirth 2007
Erythrocyte volume is a poor predictor of cobalamin and folate deficiency in geriatric patients. Heme
M 5
D
105 17823223
I Ahmed 2007
Heparin induced thrombocytopenia: diagnosis and management update. Heme
E
  PDF
106 17611006
Philip J Mason 2007
G6PD deficiency: the genotype-phenotype association. Heme
M 5
D
107 16378835
C Shane Arnold 2006
The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor. Heme
M 5
D
108 16030191
Paolo Prandoni 2005
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Heme
M 5
D
109 16093785
Amy L Dunn 2005
Management and prevention of recurrent hemarthrosis in patients with hemophilia. Heme
M 5
D
110 15981234
Jody L Kujovich 2005
von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management. Heme
M 5
D
111 15929106
Baijayantimala Mishra 2005
Human parvovirus B19 in patients with aplastic anemia. Heme
M 5
D
112 15321852
P H B Bolton-Maggs 2004
Hereditary spherocytosis; new guidelines. Heme
M 5
D
  PDF
113 15054821
David A Sears 2004
Pappenheimer bodies: a brief historical review. Heme
E
114 14989574
Sara H Mitchell , AFP 2004
A new view of occult and obscure gastrointestinal bleeding. Heme
M 5
D
115 15597353
Jennifer A Egan 2004
Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy. Heme
M 5
D
116 14667194
Elio Castagnola 2003
Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Heme
D
117 12643357
Robert Oh , AFP 2003
Vitamin B12 deficiency. Heme
M 5
D
118 12380967
Kalust Ucar 2002
Clinical presentation and management of hemolytic anemias. Heme
M 5
D
119 12380952
Jerry L Spivak 2002
Iron and the anemia of chronic disease. Heme
M 5
D
120 11882830
Gianclaudio Mecozzi 2002
Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. Heme
D
121 11807186
V Adhiyaman 2002
Chronic subdural haematoma in the elderly. Heme
E
  PDF
122 11734237
B E Serjeant 2001
Haematological response to parvovirus B19 infection in homozygous sickle-cell disease. Heme
D
123 11734237
B E Serjeant 2001
Haematological response to parvovirus B19 infection in homozygous sickle-cell disease. Heme
D
124 11744340
C H Chui 2001
Vitamin B12 deficiency--need for a new guideline. Heme
D
125 11427142
Y Verlinsky , JAMA 2001
Preimplantation diagnosis for Fanconi anemia combined with HLA matching. Heme
M 5
D
126 11409907
P L Perrotta 2001
Non-infectious complications of transfusion therapy. Heme
M 5
D
127 11011859
D L Wethers , AFP 2000
Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment. Heme
M 5
D
128 10997528
D L Wethers , AFP 2000
Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance. Heme
M 5
D
129 10735342
S H Yale , AFP 2000
Approach to the vaso-occlusive crisis in adults with sickle cell disease. Heme
M 5
D
130 10718279
D Bhowmik 2000
Total dose iron infusion: safety and efficacy in predialysis patients. Heme
D
131 9971864
P C Hébert , NEJM 1999
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. Heme
M 5
D
132 9459312
T E Warkentin 1998
Heparin-induced thrombocytopenia: towards consensus. Heme
E
133 9271712
F H Herrmann 1997
Prevalence of factor V Leiden mutation in various populations. Heme
D
134 8634234
Y A Aken'Ova 1995
Bacterial causes of acute osteomyelitis in sickle cell anaemia: changing infection profile. Heme
M 5
D
135 8520091
D P Lewis 1995
Phenytoin-folic acid interaction. Heme
D
136 1578962
I A Tabbara 1992
Hemolytic anemias. Diagnosis and management. Heme
E
137 1583389
B J Ferguson 1992
Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. Heme
E
138 2631335
B S Briskin 1989
[The diagnosis and treatment of intestinal obstruction in colonic cancer]. Heme
M 5
D
139 3431353
J Beltran 1987
Avascular necrosis of the femoral head: early MRI detection and radiological correlation. Heme
M 5
D
140 3488680
B H Bjornson 1986
Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis. Heme
E
140 matches found
Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options